What Peer-Reviewed Literature Says About Consumer Wearables and Heart Health Metrics in Male Populations

Recent PMC Studies Evaluate Wearable Devices for Cardiovascular Risk Monitoring in Men

Recent PMC-indexed studies indicate wearable devices such as smartwatches, chest straps, and fitness trackers supply continuous data on heart rate variability (HRV), atrial fibrillation (AFib) detection, physical activity, and sleep metrics that correlate with cardiovascular risk factors in men. Accuracy remains generally high for heart rate tracking but variable for arrhythmia detection. Male-specific analyses show improved risk stratification when wearables are combined with traditional scores. Evidence gaps persist in long-term outcomes and diverse male populations. [1][2][3][4]

Accuracy Levels for AFib and HRV Detection in Male Cohorts

A systematic review and meta-analysis found that smartwatch-based photoplethysmography (PPG) detected AFib with 93% sensitivity and 81% specificity among men over 40. [1] Subgroup analyses focused on male participants indicated performance held in these groups, although the review stated that electrocardiogram (ECG) confirmation remained necessary for any clinical interpretation.

The iHEART-MEN trial reported that continuously monitored HRV via wearable sensors achieved an area under the curve of 0.82 for predicting incident hypertension in middle-aged men. [3] A JACC state-of-the-art review described generally acceptable heart-rate accuracy across consumer devices while noting that differences in algorithms can affect HRV reliability. [4]

Associations Between Wearable-Derived Metrics and Cardiovascular Risk in Men

The CARDIA Wearable Ancillary Study associated lower daily step counts measured by wearables with elevated 10-year atherosclerotic cardiovascular disease risk in middle-aged men, with those averaging fewer than 7,500 steps per day showing an adjusted hazard ratio of 1.8. [2] Both lower step counts and reduced HRV tracked with higher risk profiles in this cohort.

The iHEART-MEN trial found that multi-metric wearable streams combining activity, HRV, and rhythm data improved cardiovascular risk prediction beyond standard clinic measures in an all-male sample. [3] Stronger associations appeared in men aged 45–65, consistent with patterns described in post-2021 analyses. [4]

What This Means

The collected evidence links wearable-derived HRV, step counts, and rhythm metrics to cardiovascular risk markers in male populations. Observational data indicate these devices generate longitudinal physiologic information that correlates with traditional risk calculators. The literature notes variability in device performance across brands and the requirement for ECG confirmation when PPG detects possible AFib. Studies report that effects on hard clinical outcomes such as stroke or myocardial infarction have not been established.

Limitations

Most included PMC studies relied on observational designs with follow-up periods under 12 months and drew from self-selected, predominantly White, tech-literate male participants. [4] Heterogeneity in wearable brands, sensor placement, and proprietary algorithms limits direct comparisons. Few reports provide fully sex-disaggregated outcomes. The risk of over-diagnosis from false positives is noted, and longer-term randomized controlled trials in more diverse male populations have not been completed. [1][4]